Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
123,650,000
-
Total 13F shares
-
85,679,010
-
Share change
-
-633,296
-
Total reported value
-
$846,469,840
-
Put/Call ratio
-
73%
-
Price per share
-
$9.88
-
Number of holders
-
127
-
Value change
-
-$18,663,345
-
Number of buys
-
72
-
Number of sells
-
61
Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q2 2014
As of 30 Jun 2014,
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
85,679,010 shares.
The largest 10 holders included
Third Security, LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, VANGUARD GROUP INC, BB Biotech AG, QVT Financial LP, Sectoral Asset Management Inc, BlackRock Fund Advisors, FMR LLC, State Street Corp, and BlackRock Institutional Trust Company, N.A..
This page lists
127
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.